ANI Pharmaceuticals, Inc. (ANIP) ownership: insiders 5% · institutions 101% · index and ETF funds 11% (13F 2026-03-31). Insider activity, 90 days: 8 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 2747492.00 | $211.28M | 12.5% | 2026-03-31 |
| Vanguard | 1349552.00 | $103.78M | 6.2% | 2026-03-31 |
| Soleus Capital Management, L.P. | 820243.00 | $63.08M | 3.7% | 2026-03-31 |
| State Street | 771587.00 | $59.34M | 3.5% | 2026-03-31 |
| Tang Capital Management LLC | 707500.00 | $54.41M | 3.2% | 2026-03-31 |
| Goldentree Asset Management LP | 667981.00 | $51.30M | 3.0% | 2026-03-31 |
| Deep Track Capital, LP | 600000.00 | $46.14M | 2.7% | 2026-03-31 |
| Millennium Management | 592013.00 | $45.53M | 2.7% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-07-29 | |
| Sell | null | 2026-07-18 | |
| Sell | null | 2026-07-13 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 | |
| Sell | null | 2026-07-02 |
Back to ANIP overview · ANIP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.